Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

A Survey of the Awareness, Knowledge, and Experience of Point-of-Care Devices of Doctors in Nigeria

Bolodeoku, John DPhil (Oxon), MBBS, MSc, MBA, FRCPath; Kuti, Modupe A. MBBS, FWCPath; Melichan, Brian MSc; Adebisi, Samuel A. MBBS, FWCPath

Point of Care: The Journal of Near-Patient Testing & Technology: March 2016 - Volume 15 - Issue 1 - p 22–25
doi: 10.1097/POC.0000000000000084
Original Articles

In a point-of-care test (POCT) survey carried out on 109 doctors in Nigeria, the top 3 parameters selected as important to be tested at point of care by more than 90% of the doctors were glucose (95.3%), potassium (92.5%), and hemoglobin (91.6%). Eighty-nine (82%) of the doctors had used a POCT device, with more than 40% of the them having used a device for glucose (71.6%), pregnancy testing (53.2%), urine chemistry (44%), and hemoglobin (43.1%). Less than 10% of the doctors had used a POCT device for cardiac enzymes (5.5%), drugs of abuse (4.6%), and lithium (1.8%). From a list of critical-care POCT devices consisting of traditional reusable systems (Bayer-Chiron, Radiometer-ABL, NOVA, IL-Synthesis), reusable cartridge-based systems (Radimeter-ABL70/77, IL-GEM Premier, Bayer-Rapidpoint 400), and single-use systems (Roche-AVL Opti, Abbott-i-STAT, Diametrics ITC IRMA), a total of 19 doctors (19.2%) had used the Abbott-i STAT; 6 (6.1%), the Roche-AVL Opti and the Nova; 4 (4.0%), the Bayer Chiron; 3 (3.0%), the Bayer Rapid Point 400; and 1 (1.0%), the Radiometer-ABL and the IL-GEM Premier, whereas none of the doctors had used the Radiometer-ABL 70/77, the IL-Synthesis, or the Diametrics ITC IRMA. For general POCT sampling, more than two-thirds (73%) of the doctors preferred the finger-prick sampling method.

From the *JB Consulting (MDP) Limited, Cherwell Innovation Centre, Upper Heyford, Oxfordshire, United Kingdom; †Department of Chemical Pathology, University College Hospital, Ibadan, Oyo State; and ‡College of Health Sciences, Benue State University, Makurdi, Benue State, Nigeria.

Reprints: John Bolodeoku, DPhil (Oxon), MBBS, MSc, MBA, FRCPath, JB Consulting (MDP) Limited, Cherwell Innovation Centre, 77 Heyford Park, Upper Heyford, Oxfordshire OX25 5HD, United Kingdom. E-mail:

J.B. has been a medicomarketing consultant and distributor for point-of-care manufacturers: Boditech Med Inc, Korea; Abbott Point of Care, US; and Abaxis, Germany. The other authors declare no conflict of interest.

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved